Skip to content
Open access

A multidisciplinary nutritional-behavioral intervention improves weight loss and liver-related outcomes in patients with metabolic dysfunction-associated steatotic liver disease: A randomized controlled trial.

Sep 2026 · Clinical Nutrition · Vol 66, pp. 106800 · 0 citations
Medicine

TL;DR

A high-intensity multidisciplinary behavioral care model integrating hepatological, nutritional, and CBT-based behavioral support significantly improved medium-term adherence, body composition, metabolic control, and clinically relevant outcomes in MASLD.

Abstract

Background

&

Aims

Metabolic dysfunction-associated steatotic liver disease (MASLD) is strongly associated with cardiometabolic comorbidities and increased cardiovascular risk. Despite emerging pharmacological therapies, lifestyle modification remains the cornerstone of management. However, long-term adherence to dietary and behavioral recommendations remains poor. This study evaluated the benefits of a multidisciplinary intervention integrating hepatological, nutritional, and cognitive behavioral therapy (CBT)-based support ("Co-Co-Nut") on MASLD outcomes and investigated the social determinants of health (SDOH) influencing adherence.

Methods

A total of 286 consecutively enrolled MASLD patients were initially randomized 1:1 to either the standard-of-care cohort or the experimental cohort. Patients assigned to standard care subsequently underwent a secondary 1:1 allocation into two subgroups: hepatologist-delivered generic lifestyle counselling (A, n = 72) or hepatologist plus individualized nutritional intervention (B, n = 71), whereas the experimental cohort received the full multidisciplinary intervention, including CBT-based behavioral support (C, n = 143). Anthropometric, metabolic, lifestyle, body composition, liver stiffness measurement (LSM), and controlled attenuation parameter (CAP) data were assessed at baseline and at 6, 12, and 18 months. Adherence, SDOH, and incident acute cardiovascular events (ACEs) were also recorded.

Results

The "Co-Co-Nut" intervention significantly increased the proportion of patients achieving ≥10% weight loss and induced sustained improvements in body composition, metabolic profile, LSM, and CAP, which were not observed with standard care (all p < 0.0001). Loss of adherence was significantly lower in the experimental group (p < 0.0001), which also showed a significantly lower risk of ACEs (HR 0.36, 95% CI 0.18-0.71). Adherence at 12 months independently predicted ACE risk reduction (HR 0.27). Large family size (OR 1.87), limited time for meals (OR 1.91), and full-time employment (OR 1.61) (all p < 0.0001) emerged as the SDOH most strongly associated with loss of adherence.

Conclusion

A high-intensity multidisciplinary behavioral care model integrating hepatological, nutritional, and CBT-based behavioral support significantly improved medium-term adherence, body composition, metabolic control, and clinically relevant outcomes in MASLD. The present Clinical trial registration NCT07366463 (ClinicalTrials.gov). CLINICAL TRIAL REGISTRATION NCT07366463 (ClinicalTrials.gov).

Read PDF

Similar papers

Review Open access Sep 2026

Behavioral Intervention for Lifestyle Modification in Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease

Clinical outcomes across six studies consistently demonstrate that behavioral interventions outperform standard care in weight management and the reduction of liver enzymes, and are further enhanced by eHealth interventions.

Marinda Asiah Nuril Haya, D. Prawitasari, Syifa Nur Azizah et al. · 0 citations
Open access Sep 2026

Longitudinal outcomes associated with structured exercise and dietary and microbiota-targeted care in patients with diabetic sarcopenia: a retrospective cohort study

Structured exercise combined with dietary and microbiota-targeted care was associated with more favorable muscle-related trajectories but not superior overall glycemic control, warranting confirmation in prospective randomized trials.

Xiao-Wei Huang, Jing-Yu Duan, Xue Liang et al. · 0 citations
Open access Oct 2026

Short-Term Changes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Related Circulating Biomarkers Following a Very-Low Calorie Ketogenic Diet (VLCKD): A Paired Longitudinal Analysis

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide. Its prevalence is constantly increasing, particularly among obese individuals. Lifestyle modifications remain the first-line intervention for the management and treatment of MASLD. The most w...

R. Tatoli, Rossella Donghia, P. L. Pesole et al. · 0 citations
Open access Oct 2026

Impact of a lifestyle intervention for weight loss on liver-related outcomes in adults with obesity: a subanalysis of a clinical trial

This study aimed to evaluate the impact of a structured weight-loss intervention on liver steatosis and liver stiffness in adults with obesity. Post hoc analysis of prospectively collected data from a randomized crossover trial (NCT05420311) assessing changes in liver-related outcomes measured from baselin...

Alba Rodríguez-Muñoz, J. I. Martínez-Montoro, Cristina Ma Díaz Perdigones et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.